Covovax get approved by WHO

As of Friday, Covovax has been awarded Emergency Use Listing (EUL) by the World Health Organization (WHO).

The Serum Institute of India (SII) and the US-based Novavax collaborated on the development of Covovax, a vaccine against the coronavirus illness.


Health benefits


The World Health Organization (WHO) has approved Covovax as the third Indian jab, after Covishield and Covaxin.

Covovax is a two-dose regimen that has been approved by the WHO for emergency use.


On the basis of a review of data on the quality, safety and effectiveness, as well as a risk management strategy, programmatic sustainability, and manufacturing site inspection by the Drugs Controller General of India, Covovax was evaluated under the WHO EUL protocol" (DCGI)..

“According to the World Health Organization (WHO), a panel of experts has found that the vaccine satisfies WHO requirements for Covid-19 protection, that the benefits of the vaccination greatly exceed any dangers, and that it may be administered globally.”